Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/1/20 → 3/31/25 |
Funding
- University of Southern California (Subk No. 131741611 // Subk No. 131741611)
- Eisai, Inc. (Subk No. 131741611 // Subk No. 131741611)
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer’s Disease and Elevated Amyloid (A45 Trial) and in Subjects With E
- Grant, Ian Michael (PD/PI)
Project: Research project